Go Pro

Chemed (NYSE:CHE) Posts Earnings Results

Chemed logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Chemed exceeded quarterly expectations, reporting adjusted earnings of $6.06 per share versus the $5.60 consensus estimate and revenue of $673.25 million versus $665.04 million. Revenue increased 8.8% year over year, and the company raised its FY 2026 EPS guidance to $25.00–$25.75.
  • Chemed shares rose 1.3% to $516.09, near their 52-week high, following the results. The company also declared a quarterly dividend of $0.60 per share, equivalent to a 0.5% annualized yield.
  • Analyst sentiment remains cautious: five analysts rate the stock Hold and one rates it Buy, producing a consensus Hold rating and an average price target of $480.25—below the current share price.
  • Interested in Chemed? Here are five stocks we like better.

Chemed (NYSE:CHE - Get Free Report) issued its quarterly earnings results on Tuesday. The company reported $6.06 earnings per share for the quarter, topping analysts' consensus estimates of $5.60 by $0.46, FiscalAI reports. The company had revenue of $673.25 million during the quarter, compared to analyst estimates of $665.04 million. Chemed had a net margin of 10.23% and a return on equity of 27.18%. The business's revenue for the quarter was up 8.8% compared to the same quarter last year. During the same period in the prior year, the business posted $4.27 EPS. Chemed updated its FY 2026 guidance to 25.000-25.750 EPS.

Chemed Stock Up 1.3%

Shares of Chemed stock traded up $6.75 during midday trading on Tuesday, reaching $516.09. 198,346 shares of the company's stock traded hands, compared to its average volume of 222,962. The company has a debt-to-equity ratio of 0.11, a quick ratio of 0.83 and a current ratio of 0.85. Chemed has a 52 week low of $365.20 and a 52 week high of $520.01. The company's 50 day simple moving average is $459.92 and its 200 day simple moving average is $434.09. The company has a market cap of $6.85 billion, a price-to-earnings ratio of 28.12, a price-to-earnings-growth ratio of 1.88 and a beta of 0.52.

Chemed Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 16th. Stockholders of record on Thursday, May 28th were issued a dividend of $0.60 per share. The ex-dividend date was Thursday, May 28th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.5%. Chemed's dividend payout ratio (DPR) is currently 13.08%.

Insider Buying and Selling at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction dated Friday, May 1st. The stock was sold at an average price of $421.13, for a total transaction of $842,260.00. Following the transaction, the chief executive officer owned 90,219 shares of the company's stock, valued at approximately $37,993,927.47. This represents a 2.17% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Andrea R. Lindell sold 1,347 shares of the firm's stock in a transaction that occurred on Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total value of $602,553.51. Following the completion of the transaction, the director directly owned 4,578 shares in the company, valued at $2,047,876.74. The trade was a 22.73% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Corporate insiders own 3.33% of the company's stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. Los Angeles Capital Management LLC acquired a new stake in shares of Chemed in the fourth quarter valued at about $26,000. Global Retirement Partners LLC lifted its position in shares of Chemed by 200.0% during the 4th quarter. Global Retirement Partners LLC now owns 87 shares of the company's stock worth $37,000 after purchasing an additional 58 shares during the last quarter. Geneos Wealth Management Inc. boosted its stake in Chemed by 330.4% during the 1st quarter. Geneos Wealth Management Inc. now owns 99 shares of the company's stock valued at $61,000 after purchasing an additional 76 shares during the period. Employees Retirement System of Texas acquired a new stake in Chemed in the 3rd quarter valued at approximately $64,000. Finally, Caitong International Asset Management Co. Ltd grew its holdings in Chemed by 5,333.3% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 163 shares of the company's stock valued at $73,000 after buying an additional 160 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company's stock.

Analyst Ratings Changes

CHE has been the topic of several recent analyst reports. Royal Bank Of Canada boosted their target price on Chemed from $422.00 to $436.00 and gave the stock a "sector perform" rating in a report on Monday, April 27th. Weiss Ratings upgraded Chemed from a "hold (c-)" rating to a "hold (c)" rating in a research report on Friday, July 17th. Zacks Research raised Chemed from a "strong sell" rating to a "hold" rating in a research note on Monday, April 27th. Wall Street Zen lowered Chemed from a "buy" rating to a "hold" rating in a report on Monday, June 8th. Finally, Bank of America upped their price objective on Chemed from $450.00 to $510.00 and gave the company a "neutral" rating in a report on Thursday, July 9th. One equities research analyst has rated the stock with a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat, Chemed has a consensus rating of "Hold" and an average price target of $480.25.

Read Our Latest Stock Report on Chemed

About Chemed

(Get Free Report)

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

Featured Stories

Earnings History for Chemed (NYSE:CHE)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Chemed Right Now?

Before you consider Chemed, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.

While Chemed currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines